Large pharmaceutical companies such as Pfizer and Sanofi are investing in the supplement category, a potential growth opportunity for pharmaceuticals. This category, once ignored by pharmaceutical companies, is almost as large as over-the-counter medication in terms of global retail sales. Chris Schmidt, Consumer Health Company Analyst at Euromonitor, cites several key areas of M&A activity in consumer health.

How will the US-Israel-Iran war shape business dynamics beyond the initial shocks? Visit our insights hub at euromonitor.com for free data-driven tools and resources to help you assess risks and plan for longer-term impact.